BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38237275)

  • 41. [Surgical treatment of primary liver cancer:a report of 10 966 cases].
    Xia YX; Zhang F; Li XC; Kong LB; Zhang H; Li DH; Cheng F; Pu LY; Zhang CY; Qian XF; Wang P; Wang K; Wu ZS; Lyu L; Rao JH; Wu XF; Yao AH; Shao WY; Fan Y; You W; Dai XZ; Qin JJ; Li MY; Zhu Q; Wang XH
    Zhonghua Wai Ke Za Zhi; 2021 Jan; 59(1):6-17. PubMed ID: 33412628
    [No Abstract]   [Full Text] [Related]  

  • 42. Is resection or transplantation the ideal treatment in patients with hepatocellular carcinoma in cirrhosis if both are possible? A systematic review and metaanalysis.
    Proneth A; Zeman F; Schlitt HJ; Schnitzbauer AA
    Ann Surg Oncol; 2014 Sep; 21(9):3096-107. PubMed ID: 24866437
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hepatocellular carcinoma in Child's A cirrhosis: a retrospective analysis of matched pairs following liver transplantation vs. liver resection according to the intention-to-treat principle.
    Foltys D; Zimmermann T; Kaths M; Strempel M; Heise M; Hoppe-Lotichius M; Weiler N; Scheuermann U; Ruckes C; Hansen T; Pitton M; Otto G
    Clin Transplant; 2014 Jan; 28(1):37-46. PubMed ID: 24171713
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The risk factors for long-term survival outcome in solitary hepatocellular carcinoma up to 2 cm: Propensity score matching analysis in a population cohort with a high rate of HBV infection.
    Wang G; Zhang W; Tan Y; Jiang L; Yang J; Yang J; Yan L
    Int J Surg; 2019 Dec; 72():1-6. PubMed ID: 31610283
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Resection vs Transplant Listing for Hepatocellular Carcinoma: An Intention-to-Treat Analysis.
    Meyerovich G; Goykhman Y; Nakache R; Nachmany I; Lahat G; Shibolet O; Menachem Y; Katchman H; Wolf I; Geva R; Klausner JM; Lubezky N
    Transplant Proc; 2019; 51(6):1867-1873. PubMed ID: 31399171
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of liver resection and radiofrequency ablation in long-term survival among patients with early-stage hepatocellular carcinoma: a meta-analysis of randomized trials and high-quality propensity score-matched studies.
    Hu L; Lin J; Wang A; Shi X; Qiao Y
    World J Surg Oncol; 2024 Feb; 22(1):56. PubMed ID: 38369480
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparative analysis of outcomes after liver resection and liver transplantation for early stages hepatocellular carcinoma in HIV-infected patients. An intention-to-treat analysis.
    Golse N; Duarte P; Fontana A; Bündchen C; Karam V; Allard MA; Pittau G; Ciacio O; Duclos-Vallée JC; Sa Cunha A; Castaing D; Cherqui D; Adam R; Samuel D; Vibert E
    HPB (Oxford); 2020 Jun; 22(6):900-910. PubMed ID: 31734238
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunohistochemical markers for hepatocellular carcinoma prognosis after liver resection and liver transplantation.
    Lee SH; Lee JS; Na GH; You YK; Kim DG
    Clin Transplant; 2017 Jan; 31(1):. PubMed ID: 27653235
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Is liver resection justified in advanced hepatocellular carcinoma? Results of an observational study in 464 patients.
    Ruzzenente A; Capra F; Pachera S; Iacono C; Piccirillo G; Lunardi M; Pistoso S; Valdegamberi A; D'Onofrio M; Guglielmi A
    J Gastrointest Surg; 2009 Jul; 13(7):1313-20. PubMed ID: 19418103
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The role of liver transplantation or resection for patients with early hepatocellular carcinoma.
    Hsueh KC; Lee TY; Kor CT; Chen TM; Chang TM; Yang SF; Hsieh CB
    Tumour Biol; 2016 Mar; 37(3):4193-201. PubMed ID: 26490991
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment of recurrent hepatocellular carcinoma after liver transplantation.
    Kim HR; Cheon SH; Rha SY; Lee S; Han KH; Chon CY; Lee JD; Sung JS; Chung HC
    Asia Pac J Clin Oncol; 2011 Sep; 7(3):258-69. PubMed ID: 21884437
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Factors for predicting outcomes of liver transplantation and liver resection for hepatocellular carcinoma meeting Milan criteria].
    Huang J; Zhou J
    Nan Fang Yi Ke Da Xue Xue Bao; 2014 Mar; 34(3):406-9. PubMed ID: 24670459
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Population-Based Analysis of Hepatocellular Carcinoma in Children: Identifying Optimal Surgical Treatment.
    Ziogas IA; Ye F; Zhao Z; Matsuoka LK; Montenovo MI; Izzy M; Benedetti DJ; Lovvorn HN; Gillis LA; Alexopoulos SP
    J Am Coll Surg; 2020 Jun; 230(6):1035-1044.e3. PubMed ID: 32272204
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Salvage living donor liver transplantation versus repeat liver resection for patients with recurrent hepatocellular carcinoma and Child-Pugh class A liver cirrhosis: A propensity score-matched comparison.
    Yoon YI; Song GW; Lee S; Moon D; Hwang S; Kang WH; Cho HD; Ha SM; Kim MJ; Kim SH; Na BG; Yang G; Min Kim S; Hyun Shim J; Park JI
    Am J Transplant; 2022 Jan; 22(1):165-176. PubMed ID: 34383368
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Survival and recurrence after liver transplantation versus liver resection for hepatocellular carcinoma: a retrospective analysis.
    Otto G; Heuschen U; Hofmann WJ; Krumm G; Hinz U; Herfarth C
    Ann Surg; 1998 Mar; 227(3):424-32. PubMed ID: 9527066
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Survival analysis of patients with stage I and II hepatocellular carcinoma after a liver transplantation or liver resection.
    Seshadri RM; Besur S; Niemeyer DJ; Templin M; McKillop IH; Swan RZ; Martinie JB; Russo MW; Iannitti DA
    HPB (Oxford); 2014 Dec; 16(12):1102-9. PubMed ID: 24964271
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Benefit of initial resection of hepatocellular carcinoma followed by transplantation in case of recurrence: an intention-to-treat analysis.
    Fuks D; Dokmak S; Paradis V; Diouf M; Durand F; Belghiti J
    Hepatology; 2012 Jan; 55(1):132-40. PubMed ID: 21932387
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Locoregional Therapy With Curative Intent Versus Primary Liver Transplant for Hepatocellular Carcinoma: Systematic Review and Meta-Analysis.
    Murali AR; Patil S; Phillips KT; Voigt MD
    Transplantation; 2017 Aug; 101(8):e249-e257. PubMed ID: 28282359
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cirrhosis and microvascular invasion predict outcomes in hepatocellular carcinoma.
    Barreto SG; Brooke-Smith M; Dolan P; Wilson TG; Padbury RT; Chen JW
    ANZ J Surg; 2013 May; 83(5):331-5. PubMed ID: 22943449
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long-term outcomes following aggressive management of recurrent hepatocellular carcinoma after upfront liver resection.
    Tranchart H; Chirica M; Sepulveda A; Massault PP; Conti F; Scatton O; Soubrane O
    World J Surg; 2012 Nov; 36(11):2684-91. PubMed ID: 22851144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.